Concerning ARDS treatment, it seems plausible to speculate that the anti-IL6 plays a protective role if given at the time of overly elevated immune response to the virus, thus preventing “anaphylactic toxicity”. This evidence concerns the gene IL6 and acute respiratory distress syndrome.